T
Tudor Phillips
Researcher at University of Oxford
Publications - 19
Citations - 1632
Tudor Phillips is an academic researcher from University of Oxford. The author has contributed to research in topics: Placebo & Analgesic. The author has an hindex of 16, co-authored 19 publications receiving 1262 citations. Previous affiliations of Tudor Phillips include Imperial College London & Churchill Hospital.
Papers
More filters
Journal ArticleDOI
Cannabis‐based medicines for chronic neuropathic pain in adults
TL;DR: To assess the efficacy, tolerability, and safety of cannabis-based medicines (herbal, plant-derived, synthetic) compared to placebo or conventional drugs for conditions with chronic neuropathic pain in adults, randomised, double-blind controlled trials are selected.
Journal ArticleDOI
Gabapentin for chronic neuropathic pain in adults
Philip J Wiffen,Sheena Derry,Rae Frances Bell,Andrew S.C. Rice,Thomas R. Tölle,Tudor Phillips,R Andrew Moore +6 more
TL;DR: Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage) and adverse effects in adults as discussed by the authors, and it has been shown that patients with substantial pain relief (at least 50% pain relief over baseline or very much improved on Patient Global Impression of Change scale (PGIC)) were more common with gabapentin than with placebo.
Journal ArticleDOI
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Tudor Phillips,Catherine L. Cherry,Catherine L. Cherry,Catherine L. Cherry,Sarah Cox,Sarah J. Marshall,Andrew S.C. Rice +6 more
TL;DR: Evidence of efficacy exists only for capsaicin 8%, smoked cannabis and rhNGF, and smoked cannabis cannot be recommended as routine therapy, and Evaluation of novel management strategies for painful HIV-SN is urgently needed.
Journal ArticleDOI
Topical analgesics for acute and chronic pain in adults ‐ an overview of Cochrane Reviews
Sheena Derry,Philip J Wiffen,Eija Kalso,Rae Frances Bell,Dominic Aldington,Tudor Phillips,Helen Gaskell,R Andrew Moore +7 more
TL;DR: Thirteen Cochrane Reviews assessed the efficacy and harms from a range of topical analgesics applied to intact skin in a number of acute and chronic painful conditions.
Journal ArticleDOI
Cannabinoids for fibromyalgia.
TL;DR: The primary outcomes in this review were participant-reported pain relief of 50% or greater, Patient Global Impression of Change (PGIC) much or very much improved, withdrawal due to adverse events (tolerability) and serious adverseEvents (safety).